CONFIRMED CHAIRS

72-Aas-Anne-Marie

Anne-Marie Aas

74-Dimosthenopoulos-Charilaos

Charilaos Dimosthenopoulos

87-Gregersen-Søren

Søren Gregersen

45-Jenkins-David

David Jenkins

81-Jeppesen-Per_Bendix

Per Bendix Jeppesen

47-Kahleova-Hana

Hana Kahleova

113-Kendall-Cyril

Cyril Kendall

109-Liu-Simin

Simin Liu

96-Livesey-Geoffrey

Geoffrey Livesey

251-Martínez-González-Miguel_A.

Miguel Ángel Martínez González

53-Pfeiffer-Andreas_F._H.

Andreas F. H. Pfeiffer

42-Riccardi-Gabriele

Gabriele Riccardi

253-Risérus-Ulf

Ulf Risérus

97-Rivellese-Angela_Albarosa

Angela Albarosa Rivellese

63-Sabate-Joan

Joan Sabaté

jordi-salas

Jordi Salas-Salvadó

68-Schwab-Ursula

Ursula Schwab

111-Sievenpiper-John

John Sievenpiper

254-THANOPOULOU-ANASTASIA

Anastasia Thanopoulou

288-Vuksan-Vladimir

Vladimir Vuksan

Anne-Marie Aas

Anne-Marie Aas is a clinical dietitian at Oslo University Hospital, Aker, and associate professor at the Faculty of Medicine, University of Oslo. Both work and research is focused on diabetes and nutrition. Aas has been a member of the DNSG since 2002 and the DNSG board since 2011. She has been involved in the revision of the DNSG’s dietary recommendations and had similar obligations in the Norwegian guidelines for diet, physical activity and weight reduction in diabetes.

Charilaos Dimosthenopoulos

Charilaos Dimosthenopoulos received his BSc in Biological Sciences, in 1993, in 1994 he completed his MMedSci in Human Nutrition at Sheffield University, UK and in 1996 he received his Postgraduate Diploma in Dietetics, at Leeds Metropolitan University, UK. He is PhD candidate at the Medical School of the Kapodistriakon University, Athens. He works as Chief Dietitian of the Dietetic Department of the General University Hospital of Athens “Laiko” since 2002. He has numerous publications and several abstracts and posters and he gives talks in greek and international congresses. He is member of the committee of the Greek Diabetes Association, Board Member of the Diabetes and Nutrition Study Group of the European Diabetes Association (EASD) and Lead of ESDN Diabetes of EFAD.

Søren Gregersen

Chief physician, MD, PhD, associate professor at Steno Diabetes Center Aarhus. Main research focus on type 2 diabetes and prevention by dietary means. Has studied the impact of dairy protein, dietary fat and fibres as well as bioactive food components in subjects with prediabetes and diabetes. E.g. the effects of coffee-related substances, aronia berry, sweeteners etc. has been studied in intervention trials.

David Jenkins

Dr. David J.A. Jenkins is an University Professor, and Canada Research Chair, in the Departments of Nutritional Sciences and Medicines, a staff physician in the Division of Endocrinology and Metabolism, the Director of the Clinical Nutrition and Risk Factor Modification Center, and a Scientist in the Li Ka Shing Knowledge Institute, St. Michael’s Hospital.  He was educated at Oxford University, obtaining his DM, DPhil and DSc. He is a fellow of the Royal College of Physicians (London) and of the Royal College of Physicians of Canada.  He has served on committees in Canada and the United States that formulated nutritional guidelines for the treatment of diabetes and recommendations for fiber and macronutrient intake under the joint US-Canada DRI system (RDAs) of the National Academy of Sciences.  He also served as a member of Agriculture Canada’s Science Advisory Board (2004-2009) on the future direction of Canada’s agriculture and agricultural research. He has spent much time working with the food industry to develop products for the supermarket shelf and, for example, helped to initiate Loblaw’s ‘Too Good To Be True’ and most recently their popular “Blue Menu” line of products. His research area is the use of diet in the prevention and treatment of hyperlipidemia and diabetes.  He has over 300 original publications on these and related topics.  His team was the first to define and explore the concept of the glycemic index of foods and demonstrate the breadth of metabolic effects of viscous soluble fiber, including blood glucose and cholesterol lowering. His group developed the cholesterol lowering concept of the dietary portfolio that has entered guidelines in many jurisdictions (e.g. CCS, Heart UK etc.). He believes in the therapeutic value of plant based diets and that diets have to be environmentally sustainable.

Per Bendix Jeppesen

During the last 25 years of research, Associate prof, PhD Per Bendix Jeppesen has achieved experiences as project manager in several international projects and become a leading expert in bioactive compounds and their physiological effects. Especially, a high expertise in clinical human and animal studies on carbohydrate and lipid metabolism, diabetes metabolism as well as Sport Nutrition and performance. His focus has also been on sweeteners in relation to health e.g. the effect of fructose, artificial and natural sweeteners in relation to life-style diseases. He has served as primary advisor for 18 PhD dissertations 17 defended, and 21 M.Sci. 12 patents and 117 publications in peer reviewed journals. More than 160 oral presentations and posters presented at international scientific meetings, symposiums and congresses and 42 popular papers. Scientific reviewer for more than 35 international journals. He has been a board member of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the study of Diabetes (EASD) from 2010- 2018 and honorary member of the European Stevia Association (EUSTAS), Full Voting member, since 2009. Per Bendix Jeppesen is visiting Professor at Guangdong pharmaceutical University, Guangzhou, China, and Scientific adviser and collaborator with the Sierra Maestra project, Ministry of Health in Cuba. Further, he has been the co-founder of the Nutritional education at Aarhus University “Molecular Nutrition and Food Technology Science” established in 2008.

Hana Kahleova

Hana Kahleova, M.D., Ph.D., M.B.A.

Dr. Kahleova is director of clinical research for the Physicians Committee for Responsible Medicine. She has conducted several clinical trials, using a plant-based diet in the treatment of obesity, diabetes, and metabolic disease. Her research showed that a plant-based diet leads to a greater weight loss and improvement in metabolism, and addresses multiple mechanisms behind diabetes.

Her research proved that eating a large breakfast and lunch is more beneficial than eating six smaller meals a day for patients with type 2 diabetes. Her research on meal frequency and timing showed that eating less frequently, no snacking, consuming breakfast, and eating the largest meal in the morning may be effective methods for preventing long-term weight gain.

As a member of the American Diabetes Association and as a board member of the Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes, Dr. Kahleova is directly involved in the process of updating the nutritional recommendations for patients with diabetes.

Cyril WC Kendall

Dr. Kendall is a Senior Research Associate, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, and Clinical Nutrition and Risk Factor Modification Center, St. Michael's Hospital. His primary research interest is the role of diet in the prevention and treatment of chronic disease (cardiovascular disease, diabetes and obesity) and has over 200 publications. He is a founding member of the International Carbohydrate Quality Consortium (ICQC), Vice President of the Diabetes and Nutrition Study Group of the (EASD), on the Nutrition Therapy Guidelines Committee of the EASD and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation.

Simin Liu

I began my career in infectious disease epidemiology and nutrition as an Epidemic Intelligence Service (EIS) Fellow at the CDC in 1993. Since 1995, I have been an NIH-supported investigator or Principal Investigator (PI) in numerous research programs, prospective cohort studies, and clinical trials both in the United States (U.S.) and internationally. My work ranges from the basic inquiry of genetic variations underpinning cardiometabolic outcomes to clinical risk stratification modeling and interventions. Work of my research group and others have pointed to the importance of environmental and/or nutritional trace elements and minerals in affecting chronic diseases. Currently, I am PI of three R01s that are designed to investigate the full spectrum of heavy metals exposure and their interactions with dietary trace elements in affecting cardiometabolic outcomes in China, Brazil, and the US, respectively. I hope that my scientific expertise, experience, and reputation earned from >25 years of molecular, clinical, and epidemiologic research will contribute to the success of this international symposium.

Geoffrey Livesey

Dr Livesey graduated in Biochemistry (BSc Hons 1st Class, Surrey University, UK), gained a second degree, in tissue biology (PhD, Keele University, UK) and undertook his post-doctorate on branched chain amino acid metabolism in Prof Sir H.A.Kreb’s Laboratory (Radcliffe Infirmary, Oxford, UK). Subsequently he joined Prof D.A.T. Southgate’s Nutrition Laboratories at the Institute of Food Research (Norwich, UK) from where he was able to collaborate with colleagues at the MRC Dunn Nutrition Unit (Cambridge UK) the Norfolk and Norwich University Hospital, Diabetes Centre (Norwich UK) and variously colleagues throughout Europe. Currently Dr Livesey is Director of Independent Nutrition Logic Ltd, Wymondham, UK. Since moving to Norwich Dr Livesey has contributed in various ways to: the British Nutrition Foundations (UK) on their review of Complex carbohydrates in Foods; the FAO/WHO/UNU (Rome) update on Protein and Energy Requirements; the Institute of Medicine (Washington DC, USA) on their Macronutrient Requirements, with particular attention to chapters on Diet and Health, Dietary Fiber, and Carbohydrates; the FAO (Rome) on their review on Methods of Analysis and Modes of Expression of Food Energy; the WHO/FAO scientific update the Physiology of Carbohydrates and Maintenance of Health; the European Polyol Association (Brussels) expert group on the Health Potential of Polyols with Emphasis on Glycaemic Properties; expert tasks of the International Life Sciences Institute (ILSI) on topics of: Glycaemic Response and Health with ILSI Europe, Food Quality, Health and Post-Prandial Metabolism with ILSI Europe, Lifestyle and Health with ILSI Europe (Brussels), Fructose and Health with ILSI International (Washington, DC); Calorie Control Council (USA) on the Energy Value of Polyols and Dietary fiber; and the International Carbohydrate Quality Consortium on Glycaemic Index and Load and Health. Interpretation of the scientific evidence from a regulatory perspective has formed an integral part of Dr Livesey’s work and has seen him in more specialised interactions with both the food industry (e.g. Isomalt, Sudzucker, (Beneo Institute, DE), Danisco (UK, USA), MD/Arala Foods (DK), Danone (EU), Mitsutani (JPN), Russel Stova (USA), Colloides Natural International (FR) and with governmental regulatory agencies (e.g. Food Standards Agency UK; Health Protection Branch, Canada; Food Standards Australia New Zealand; National Nutrition Council, China; Food and Drug Administration, USA). Dr Livesey became a member of DNSG in 2015 presenting on Glycaemic index and Load and Diabetes. His professional memberships include the Nutrition Societies of Great Britain, America and Canada, Association for Nutrition (UK), Accumentia (professional bioscience consultants, UK), SENSE (professional nutrition consultants, UK) and the Royal Society of Medicine as Fellow (London, UK) .

Miguel Ángel Martínez-González

Full Professor and Chair, Department of Preventive Medicine & Public Health, University of Navarra, Pamplona, Spain.

Adjunct Professor, Department of Nutrition, Harvard TH Chan School of Public Health, Harvard University, Boston, USA.

Group Coordinator, CIBER-OBN, Spanish National Institute of Health (ISCIII).

Medical epidemiologist of chronic disease with 30 years of experience and a worldwide expert in the Mediterranean diet as a preventive approach for diabetes, cardiovascular disease, obesity and other chronic diseases. He is the Principal Investigator (PI) of the SUN project (prospective dynamic cohort study investigating Mediterranean diet and chronic disease with around 23,000 participants and mean follow-up >12 years). Coordinator of the PREDIMED Research Network funded by the Spanish NIH (2006-2013). PREDIMED conducted the largest randomized primary cardiovascular prevention trial with nutrition in Europe including 7447 participants in a Mediterranean dietary intervention. Prof. Martínez-González also was the PI of the European Research Council Advanced Research Grant to fund the PREDIMEDPLUS trial (http://cordis.europa.eu/project/rcn/188509_en.html), an on-going trial with 6,874 participants.
He has been Co-PI of several NIH-funded grants on metabolomics, focused on type 2 diabetes and cardiovascular disease (http://medpreventiva.es/HUqpLE).
He is editor of the textbooks in Biostatistics (Bioestadística amigable, Elsevier, 4th ed), Epidemiology (Epidemiología aplicada, Ariel 2nd ed) and Public Health (Conceptos de salud pública, Elsevier, 2nd ed) recommended in Medical Schools teaching in Spanish.

Andreas F. H. Pfeiffer

Prof. Dr. Andreas F. H. Pfeiffer is Senior Professor Endocrinology & Diabetes at the Charité Universitaetsmedizin Berlin. His interests cover dietary interventions for treatment and prevention of type 2 diabetes. Hormonal and nutritional interplay in metabolism, focus on NAFLD / NASH, genetic and epigenetic factors in metabolic regulation. He coauthored over 400 peer reviewed publications.

Gabriele Riccardi

Professor of Endocrinology and Metabolic Diseases, Federico II University,  Naples, Italy
graduated with honors in Medicine at the University of Naples; then he spent two years as Visiting Scientist at the King Gustav V Research Institute, Karolinska Hospital in Stockholm. He has been President of the Italian Diabetes Society and was awarded the Celso Prize for his outstanding contribution to diabetes research.

GR has extensive experience in the field of nutrition and metabolic diseases (diabetes mellitus, lipid disorders, metabolic syndrome). He has been Editor-in-Chief of Nutrition, Metabolism and Cardiovascular Diseases, an international scientific journal published by Elsevier.
He is author of over 400 in extenso peer reviewed publications (total impact factor > 600) which have been cited over 15000 times. H-Index= 60.

Ulf Risérus

Ulf Risérus is currently a professor in clinical nutrition and metabolism, and head of the clinical nutrition research unit at Uppsala university, Sweden. Risérus conducted his basic medical training at Karolinska Institutet in Stockholm, Sweden and earned a PhD degree in nutrition at Uppsala University in 2002. After 2 years of postdoctoral training at Oxford Centre of Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford University, he has lead a research group at the Dept. of public health and caring sciences, targeting dietary prevention and management of type 2 diabetes and cardiovascular disease, with special expertise in fatty acids. Risérus has been the principal investigator of a number of clinical feeding trials focusing on the effects of different dietary fatty acids on liver fat and non-alcoholic fatty liver disease (NAFLD), insulin resistance and type 2 diabetes. Risérus has >200 peer-reviewed publications with >12.500 scientific citations, and a H-index of 54 (Scopus.com). Risérus was the president of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD) between 2012-2018, and is currently also coordinating the work with new evidence-based clinical guidelines for dietary fat in the treatment of diabetes in Europe.

Angela Albarosa Rivellese

Full Professor of Applied Technical and Dietetic Sciences.

Angela Rivellese graduated with honors in Medicine, at the University of Naples, Italy, where she got her post-graduate degree in Endocrinology in 1978 and in Internal Medicine in 1983. She was Research Assistant at the Endocrine Unit, Hammersmith Hospital, London from 1975 to 1976 and Visiting Professor at the Department of Medicine, University of Helsinki in 1993.
From 1980 to 2004 she was appointed Researcher at the Department of Clinical and Experimental Medicine of the Federico II University of Naples, from 2004 to 2015 Associate Professor of Internal Medicine and from 2015 to date Full Professor of Applied Technical and Dietetic Sciences.
From 2004 to 2007 she served as Chairman of the Study Group on Diabetes and Nutrition of the European Association for the Study of Diabetes, and from 2014 to date as Chairman of the Study Group on Diabetes and Atherosclerosis of the Italian Diabetes Society. From 2006 to 2016, she was Chairman of the Undergraduate course in Dietetics of the Federico II University of Naples and from 2016 to date Chairman of the Master Degree in Human Nutrition.
Her research activity focuses on nutrition and metabolic diseases; diabetes and lipid metabolism; diabetes and cardiovascular diseases, with particular experience in intervention clinical trials.
She is author of more than two hundred full papers on peer-reviewed, international journals (total I.F. > 800).
Since 2008 she has been serving as associate editor for the Journal Nutrition Metabolism and Cardiovascular Diseases and from 2018 to date as First Editor for the British Journal of Nutrition.

Joan Sabaté

Joan Sabaté MD, DrPH, is Professor of Nutrition and Epidemiology at Loma Linda University School of Public Health where he directs the Center for Nutrition and Healthy Lifestyles. Dr. Sabaté was the principal investigator of a nutrition intervention trial that directly linked the consumption of walnuts to significant reductions in serum cholesterol, published in the New England Journal of Medicine in 1993, and is also co-investigator of the Adventist Health Studies prospective epidemiological studies relating dietary intake with health outcomes that have the largest cohort of vegetarians.  For the past 10 years he has been the principal investigator of many clinical trials investigating the health effects of nuts and other plant foods. Dr. Sabaté has also directed the Environmental Nutrition research program at the Loma Linda University School of Public Health that focuses on sustainable diets and explores the interrelationships between the environmental and health impacts of food choices, and ultimately seeks to improve the sustainability, health and equity of food systems.

Jordi Salas-Salvadó

Professor of Nutrition and Distinguished Professor (URV), and Director of the Human Nutrition Unit of the
Rovira i Virgili University (URV) and ICREA Academy Investigator by Catalan Institution of Research and
Advanced Studies, holding teaching and research positions in URV since 1988.

Currently, he is the Clinical Head of the Nutrition Unit at the Internal Medicine of the University Hospital Sant
Joan of Reus; Vice-Director of the Pere i Virgili Health Research Institute (IISPV) and Principal Investigator of the
CIBER Pathophysiology of Obesity and Nutrition (CIBERobn) of the Carlos III Health Institute and coordinator of
its Nutrition Program. He is also the Director of the Catalan Center of Nutrition of the Institute of Catalan
Studies (CCNIEC), Director of the INC-World Forum for Nutrition Research and Dissemination Chair of the Rovira
I Virgili University and is a Member of the Expert Group of Public Health Agency of Catalonia of the Generalitat
de Catalunya (ACSA).
At the international level, he is the Chairman of the World Forum for Nutrition Research and Dissemination at
the International Nut and Dried Fruit Foundation (INC); Member of the Scientific Committee of the International
Carbohydrate Quality Consortium (ICQC); Member of the Panel of Experts of the Diabetes and Nutrition Study
Group (DSNG) of the European Association for the Study of Diabetes (EASD) and Member of the Scientific
Committee of the Danone International Institute.
Has been declared by Clarivate Analytics as "Highly Cited Researcher"; in the years 2018, 2019 and 2020 as one
of the most cited researchers in the world. He has published more than 650 scientific articles, adding more than
25500 citations and has published 14 books, with an SCI H-index 75. Editor of 14 books and co-author of more
than 65 other books. He has presented more than 470 communications in national and international
conferences.
Since 1983 Dr. Salas-Salvadó has directed more than 30 research projects funded by public agencies (DGICYT,
the Ibero-American Cooperation Institute, the Carlos III Health Institute - FIS, PROFIT, CICYT and the European
Parenteral and Enteral Nutrition project) and 25 projects in collaboration with pharmaceutical industries and
food industries. He has also participated as a Co-Investigator and as a Co-Principal Investigator in other projects
funded by the Carlos III Health Institute - FIS, the European Commission, the National Institute of Health (USA)
and the Institute of Health Studies of the Generalitat de Catalunya.
Dr. Salas' research has focused on clinical trials in humans to evaluate the effect of food, dietary compounds
and dietary patterns on obesity, diabetes, metabolic syndrome and cardiovascular diseases. Since 2005, he is
one of the leaders of the PREDIMED Study (n=7447 participants), and is currently Coordinator and Chairman of
the Steering Committee of the PREDIMED-Plus study (n=6874 participants), two large clinical trials for the
primary prevention of cardiovascular disease and mortality. PREDIMED-Plus is a multi-collaborative project
involving 30 research groups, and had received National, European & USA grants. With all these projects and
collaborations, we have also developed skills in precision medicine using different OMIC´s
methodologies, especially metabolomics, which we are now implementing in epidemiologic and clinical studies.
His scientific and academic work has been recognized through multiple awards and recognitions among which
stand out: Corresponding member of the Royal Academy of Medical Sciences of Catalonia and the Balearic
Islands (2014-present), Academic of the Spanish Academy of Nutrition (2009-present), Full Member of the
Biological Sciences Section of the Institut d'Estudis Catalans (2013-present); Dupont Prize of Science (2014),
Josep Trueta Award to his scientific career by the Academy of Medical Sciences of Catalonia and the Balearic
Islands (2012), Award to his scientific career by the Spanish Academy of Nutrition (2014), Awarded for the
scientific and human career by the University of Navarra (2013), Prize of the Scientific and Clinical trajectory by
the Spanish Society of Parenteral and Enteral Nutrition (2014). Recently he has been awarded by the Council on
Lifestyle and Cardiometabolic Health's Award from the American Heart Association Council on Lyfestile and
Cardiometabolic Health (2016), the “Creu de Sant Cosme i Sant Damià” distinction for scientific career, awarded
as the highest recognition of the Illustrious College of Doctors of the Province of Tarragona (2019) and the
Narcís Monturiol Award for scientific and technological merits, awarded by the Generalitat of Catalunya (2020).

Ursula Schwab

Professor of Nutrition Therapy at the University of Eastern Finland. Her research is based on randomized controlled dietary inervention studies examining the effects of nutrients, diet and lifestyle on metabolism and risk of non-communicable diseases. The focus is on the health effects of the quality of dietary fat, dietary fiber and dietary patterns, genetic background included.

John Sievenpiper

Dr. Sievenpiper is a Clinician Scientist who holds appointments as an Associate Professor in the Departments of Nutritional Sciences and Medicine and the Lifestyle Medicine Lead in the MD Program at the University of Toronto and a Staff Physician in the Division of Endocrinology & Metabolism and Scientist in the La Ka Shing Knowledge Institute at St. Michael’s Hospital. Dr. Sievenpiper completed his MSc, PhD and Postdoctoral Fellowship training in the Department of Nutritional Sciences at the University of Toronto. He completed his MD at St. Matthew’s University followed by Residency training in Medical Biochemistry at McMaster University leading to his certification as a Fellow of the Royal College of Physicians of Canada (FRCPC). He has established an internationally recognized research program focused on using randomized controlled trials and systematic reviews and meta-analyses to address questions of clinical and public health importance in relation to diet and cardiometabolic disease prevention with a particular interest in the role of sugars, carbohydrate quality, and plant-based dietary patterns. He is directly involved in knowledge translation with appointments to the nutrition guidelines’ committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada. He is the recipient of numerous awards including a CNS Young Investigator Award, PSI Foundation Graham Farquharson Knowledge Translation Fellowship, Diabetes Canada Clinician Scientist Award, Banting & Best Diabetes Centre Sun Life Financial New Investigator Award, and CIHR-INMD/CNS–New Investigator Partnership Prize. He has authored > 200 scientific papers and 17 book chapters.

Anastasia Thanopoulou

Born in 1965 in Indianapolis, Indiana, USA she received her Medical Doctor’s Degree in 1989 from the Aristotelian University of Salonica with grade Excellent, having a National Scholarship for her studies, and her Doctorate Degree from the same University in 1998 with Grade A. In 1999 she received a Certified Diploma - Specialisation in Internal Medicine and in 2002 the Sub-Specialization in Diabetes Mellitus. From 1999 till 2005 she served as Senior Instructor of Medicine in the Technological Educational Foundation of Athens and as a Research Associate in the Diabetes Center of the 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece. From 2005 till 2011 she served as a Lecturer in Internal Medicine and Diabetes Mellitus in Medical School, National and Kapodistrian University of Athens, Greece and from 2011 till present as Assistant Professor (from 2015 in Tenure Rank). From 2012 she is the Scientific Director of the Diabetes Center of the 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece. She is the Advisor for Academic Matters of the medical students of her clinic and the Responsible for the field of Internal Medicine for the School of Dentistry, National and Kapodistrian University of Athens (2011 – present). At present she is the Supervisor in 5 doctoral theses of medical doctors. She has given more than 150 invited lectures in International and Greek Symposia and Conferences. She is a member of 7 International and Greek professional societies and has served as the Secretary of the Board of the Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes (2010-2013). She has received various honours and awards. She is or has been Program Director - Principal Investigator or Co-Investigator of multiple scientific Projects either funded by the Greek state or by other bodies. Some of the projects are part of international collaborations. She has been Co-organizer in 25 Greek and 2 International Conferences and Chair of the Local Organizing Committee of the 30th International Symposium on Diabetes and Nutrition of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), held in Athens, Greece, in 2012. She has authored or co-authored 70 abstracts of oral presentations in international congresses and 65 in Greek congresses. She has authored or co-authored 38 full articles in international SCI journals with personal mean impact factor 10.341. She has served as Reviewer in 23 international Journals and 1 Greek, reviewing of 93 papers. She is the Co-editor of a Greek book and has written chapters in 41 educational and other Greek books. Her current research interests include Diabetes Comorbidities, Nutrition and diabetes, Drugs adverse effects, Insulin resistance, Liver and Diabetes.

Vladimir Vuksan

Dr. Vuksan is a professor of the Department of Nutritional Sciences and the Department of Medicine within the Faculty of Medicine at the University of Toronto. He also holds the position as Associated Director of the Clinical Nutrition and Risk Factor Modification Center at St. Michael’s Hospital.
Over the last 20 years, Dr. Vuksan has made significant contributions to research within a unique multidisciplinary group investigating the physiological effects of dietary and herbal interventions. His research has identified several therapies that focus on translational impact, including a propriety blend of viscous fibres (USA and Canadian patent granted), an ancient whole grain (Salba-Chia) consequently now marketed worldwide, various types of ginseng species and their chemical fractions, and dietary nitrate interventions. He has published over 150 original research publications, including many in leading medical journals.
Dr. Vuksan has received numerous awards in recognition of his contribution to nutrition, including the 2010 Charles H. Best Award from the Canadian Diabetes Association for his translational work in diabetes; 2012 Korean National, World Science Award for his studies of ginseng, and in 2014 he received the Graduate Teaching Award, Faculty of Medicine, University of Toronto, in recognition of excellence in graduate student mentorship.